Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective Cohort Study to Evaluate the Efficacy and Safety of Traditional Chinese Medicine as an Adjuvant Treatment for Patients With Severe COVID-19

NCT04323332 is registered in ClinicalTrials.gov with Xiyuan Hospital of China Academy of Chinese Medical Sciences as lead sponsor.

NCT NCT04323332
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04323332 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective Cohort Study to Evaluate the Efficacy and Safety of Traditional Chinese Medicine as an Adjuvant Treatment for Patients With Severe COVID-19
Lead sponsor
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Phase
Phase 3
Overall status
Unknown status
Start date
March 31, 2020
Completion date
April 30, 2020
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19